Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial - Thiele, EA; Marsh, ED; French, JA; Mazurkiewicz, MB; Benbadis, SR; Joshi, C (Lancet, 2018)
10125